Finance

Lists
DVAI34:BVMF
Davita Inc BDR
R$916,49
0,00%
(0,00) 1D
31 Aug., 14:27:23 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DVAI34...
Mkt. cap
11,24 mjd
Avg. vol.
8,00
Volume
0,00
52-wk high
R$1 253,26
52-wk low
R$546,63
Shares outstanding
63,80 m
No. of employees
78 k
Mkt. cap
11,24 mjd
Avg. vol.
8,00
Volume
0,00
52-wk high
R$1 253,26
52-wk low
R$546,63
Shares outstanding
63,80 m
No. of employees
78 k
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc BDR
CEOJavier J. Rodriguez
Employees78 k
Founded1992
HeadquartersDenver, Colorado, Verenigde State van Amerika
SectorHealth care provider
Websitedavita.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,42 mjd
3,62 mjd
3,42 mjd
3,55 mjd
Cost of goods sold
2,33 mjd
2,41 mjd
2,34 mjd
2,39 mjd
Cost of revenue
2,33 mjd
2,41 mjd
2,34 mjd
2,39 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,67 m
472,36 m
421,91 m
423,46 m
Operating expense
580,16 m
659,06 m
599,74 m
591,27 m
Total operating expenses
2,91 mjd
3,07 mjd
2,94 mjd
2,98 mjd
Operating income
507,30 m
551,20 m
473,55 m
570,82 m
Other non operating income
-17,26 m
-21,03 m
639,00 k
4,47 m
EBT including unusual items
308,80 m
382,76 m
341,23 m
435,01 m
EBT excluding unusual items
351,55 m
391,79 m
341,23 m
437,04 m
Income tax expense
68,55 m
76,73 m
66,20 m
91,79 m
Effective tax rate
22,20%
20,05%
19,40%
21,10%
Other operating expenses
-
-
-
-
Net income
150,33 m
234,22 m
197,53 m
265,40 m
Net profit margin
4,40%
6,47%
5,78%
7,47%
Earnings per share
2,51
3,40
2,87
4,02
Interest and investment income
-
-
-
-
Interest expense
-148,66 m
-148,25 m
-141,30 m
-146,42 m
Net interest expenses
-148,66 m
-148,25 m
-141,30 m
-146,42 m
Depreciation and amortization charges
177,49 m
186,70 m
177,83 m
167,81 m
EBITDA
684,80 m
737,91 m
651,38 m
738,62 m
Gain or loss from assets sale
-
-17,55 m
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme